tiprankstipranks
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG

Bright Minds Biosciences (DRUG) Technical Analysis

12 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Bright Minds Biosciences’s (DRUG) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Bright Minds Biosciences is a Sell.
Bright Minds Biosciences’s (DRUG) 20-Day exponential moving average is 1.08, while Bright Minds Biosciences’s (DRUG) share price is $1.06, making it a Buy.
Bright Minds Biosciences’s (DRUG) 50-Day exponential moving average is 1.11, while Bright Minds Biosciences’s (DRUG) share price is $1.06, making it a Buy.

Bright Minds Biosciences (DRUG) Pivot Points

Jul 23, 2024, 03:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.85
0.95
1.02
1.12
1.19
1.29
1.36
Fibonacci
0.95
1.01
1.06
1.12
1.18
1.23
1.29
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bright Minds Biosciences (DRUG) Moving Averages

Jul 23, 2024, 03:24 PM
Period
Simple
Exponential
MA5
1.14Buy
1.13Buy
MA10
1.07Buy
1.10Buy
MA20
1.07Buy
1.08Buy
MA50
1.09Buy
1.11Buy
MA100
1.19Sell
1.23Sell
MA200
1.41Sell
1.49Sell
Bright Minds Biosciences’s (DRUG) 10-Day exponential moving average is 1.10, while Bright Minds Biosciences’s (DRUG) share price is $1.06, making it a Buy.
Bright Minds Biosciences’s (DRUG) 100-Day exponential moving average is 1.23, while Bright Minds Biosciences’s (DRUG) share price is $1.06, making it a Sell.
Bright Minds Biosciences’s (DRUG) stock price is $1.06 and Bright Minds Biosciences’s (DRUG) 50-day simple moving average is 1.09, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) stock price is $1.06 and Bright Minds Biosciences’s (DRUG) 100-day simple moving average is 1.19, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) stock price is $1.06 and Bright Minds Biosciences’s (DRUG) 200-day simple moving average is 1.41, creating a Sell signal.

Bright Minds Biosciences (DRUG) Technical Indicators

Jul 23, 2024, 03:24 PM
Name
Value
Implied Action
RSI (14)
55.89
Neutral
STOCH (9,6)
47.41
Neutral
STOCHRSI (14)
47.41
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
20.73
Neutral
Williams %R
-48.89
Buy
CCI (14)
152.63
Sell
ATR (14)
0.11
-
Ultimate Oscillator
43.70
Neutral
ROC
6.91
Buy
Bright Minds Biosciences’s (DRUG) Relative Strength Index (RSI) is 55.89, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Trend Strength Indicator (ADX) is 20.73, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Commodity Channel Index (CCI) is 152.63, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) Price Rate of Change (ROC) is 6.91, creating a Buy signal.

FAQ

Is DRUG a Buy, Hold, or Sell?
Based on DRUG’s technical indicators, DRUG is a Buy.
    What is DRUG’s RSI (14)?
    DRUG’s RSI (14) is 55.89, which suggests DRUG is a Neutral.
      What is DRUG’s MACD?
      DRUG’s MACD is <0.01, which suggests DRUG is a Sell.
        What is DRUG’s 5-day moving average?
        DRUG’s 5-day moving average is 1.14, which suggests DRUG is a Buy.
          What is DRUG’s 20-day moving average?
          DRUG 20-day moving average is 1.07, which suggests DRUG is a Buy.
            What is DRUG’s 50-day moving average?
            DRUG’s 50-day moving average is 1.09, which suggests DRUG is a Buy.
              What is DRUG’s 200-day moving average?
              DRUG’s 200-day moving average is 1.41, which suggests DRUG is a Sell.
                What is DRUG’s Williams % R (14)?
                DRUG’s Williams % R (14) is -48.89, which suggests DRUG is a Buy.
                  What is DRUG’s CCI (14)?
                  DRUG’s CCI (14) is 152.63, which suggests DRUG is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis